An article in the British Medical Journal caught my eye as it talks informaing local level decision making. It raised the issue of the gaps due to the remit of some agencies like the National Institute for Health and Clinical Excellence (NICE) in the UK. The authors make the point that while NICE decides on what should be funded by the National Health Service it does so in a setting where there are no funds ringfenced for the new interventions approved. As no specific guidance is given on what should be 'un-funded' the process of NICE guidance can contribut to the postcode prescribing it is supposed to decrease. Of course NICE has increased its guidance for implementation and it is possible that this type of guidance may become part of that initiative in the future.
Worth a read:
See BMJ November 25th edition How much will Herceptin really cost?
by Ann Barrett, Tom Roques, Matthew Small, and Richard D Smith
(free for week then subscription needed)
http://www.bmj.com/cgi/content/short/333/7578/1118?etoc
posted by Arthur @ 3:19 AM
0 Comments:
Post a Comment
<< Home